The safety and efficacy of Desflurane for modified electrical convulsive therapy
Not Applicable
- Conditions
- Major depressive disorder, Schizophrenia, Bipolar disorder
- Registration Number
- JPRN-UMIN000020746
- Lead Sponsor
- Department of Anesthesiology and Intensive Care Medicine, Graduate School of Medicine, Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients unable to give informed consent to volunteer for this trial 2) When mECT is contraindicated Absolute contraindications: Known pheochromocytoma Relative contraindications: increased intracranial pressure, brain tumors, recent stroke, cardiovascular conduction defects, high-risk pregnancy, aortic and cerebral aneurysms, and Asthma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time for full recovery after modified electric convulsive therapy.
- Secondary Outcome Measures
Name Time Method Outcomes measured during each session 1) Heart rate, blood pressure, Bispectical Index during general anesthesia 2) Cumulative EEG duration, Visual seizure duration Outcomes measured at time points of the physician's discretion 1) PANSS 2) HAM-D 3) Global Assessment of Functioning 4) Clinical Global Impression of Change 5) Mini Mental State Examination